european organisation for research and treatment of cancer

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

125 documents for european organisation for research and treatment of cancer

- Exelixis Announces Second Quarter 2010 Financial Results.
... reimbursement revenue relating to our 2008 cancer collaboration with Bristol-Myers Squibb Company. T...Research and development expenses for the quarter ended Jun... trial) for presentation at the European Organisation for Research and Treatment of Cancer ...
- Business Wire
- August 05, 2010
- Sarah Cannon Research Institute to Present Clinical Trial Findings at International Conference for Oncology Drug Development.
... present the findings of several important cancer trials during the AACR-NCI-EORTC International Con...Conference organizers include the European Organisation for the Research and Treatment of Can...
- Business Wire
- November 12, 2011
- The role of Phototherapy in cutaneous T-cell lymphoma.
... has been proven an effective treatment modality for CTCL, in particular early stage disea... defined by The World Health Organization-European Organization for Research and Treatment of Cancer .... (40.) European Organisation for Research and Treatment of Cancer. Protocol 210...
- Journal of Drugs in Dermatology
- Vol. 9 Nbr. 7, July 2010

- Ardea Biosciences Announces Progress of Clinical Development Programs and Reports Third Quarter and Year-to-Date 2008 Financial Results.
... of small-molecule therapeutics for the treatment of human immunodeficiency virus (HIV), gout, cance.... Cancer . * Initiated a Phase 1/2 study of RDEA119 in comb...), National Cancer Institute (NCI), and European Organisation for Research and Treatment of Cancer ...
- Business Wire
- November 13, 2008
- Rtog Study Likely Treatment Option for Brain Tumor Patients Like Sen. Kennedy
To: NATIONAL EDITORS Contact: Shawn Farley, Public Relations for the Radiation Therapy Oncology Group, +1-703-648-8936, sfarley@acr.org

... domestically by the RTOG, a clinical research component of the American College of Radiology (AC... Chief Medical Officer of the Emory Winship Cancer Institute. The rate of patient enrollment has exce...The European Organisation for Research and Treatment of Cancer ...
- U.S. Newswire
- May 22, 2008
- Merck KGaA: Study Shows Cilengitide Increased Overall Survival in Patients With Glioblastoma.
... KGaA, Darmstadt, Germany, to personalizing cancer care with innovative, targeted therapies, cilengit...Pooling together the results from both treatment arms, patients in this randomized study experience... conducted in collaboration with the European Organisation for Research and Treatment of Cancer ...
- Business Wire
- May 31, 2009
- Exelixis Announces Third Quarter 2009 Financial Results.
... offset by the conclusion of the research term of various collaboration agreements with Glax...-3 kinase (PI3K) for the treatment of cancer. . * Advanced broad development efforts ... and accepted for presentation at the European Organisation for Research and Treatment of Cancer ...
- Business Wire
- October 29, 2009
- Ardea Biosciences Presents Preclinical Data on its Lead MEK Inhibitor, RDEA119, Demonstrating Synergy with Other Anti-Cancer Agents in Multiple Tumor Types.
... ERK kinase (MEK) inhibitor at the 20th European Organisation for Research and Treatment of Cancer ...
- Business Wire
- October 24, 2008
- Clock Genes, Tumor Suicide, Tailored Therapies Among Subjects of AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
..., the American Association for Cancer Research (AACR), jointly with the National Cancer Institutee (NCI) and the European Organisation for Research and Treatment of Cancer ...
- Business Wire
- November 12, 2003
- Data from Tarceva Clinical Trial Program Presented at American Society of Clinical Oncology Annual Meeting.
...-Line, Monotherapy Non-Small Cell Lung Cancer Data Presented . --Symptom Response / Quality of L... II Trial of Erlotinib in First-line Treatment for Advanced Non-small Cell Lung Cancer - Giuseppe...The protocol employed the European Organisation for Research and Treatment of Cancer ...
- Business Wire
- May 17, 2005